Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Mol Neurobiol ; 55(5): 4098-4106, 2018 May.
Artículo en Inglés | MEDLINE | ID: mdl-28593435

RESUMEN

Hypoxanthine is the major purine involved in the salvage pathway of purines in the brain. High levels of hypoxanthine are characteristic of Lesch-Nyhan Disease. Since hypoxanthine is a purine closely related to ATP formation, the aim of this study was to investigate the effect of intrastriatal hypoxanthine administration on neuroenergetic parameters (pyruvate kinase, succinate dehydrogenase, complex II, cytochrome c oxidase, and ATP levels) and mitochondrial function (mitochondrial mass and membrane potential) in striatum of rats. We also evaluated the effect of cell death parameters (necrosis and apoptosis). Wistar rats of 60 days of life underwent stereotactic surgery and were divided into two groups: control (infusion of saline 0.9%) and hypoxanthine (10 µM). Intrastriatal hypoxanthine administration did not alter pyruvate kinase activity, but increased succinate dehydrogenase and complex II activities and diminished cytochrome c oxidase activity and immunocontent. Hypoxanthine injection decreased the percentage of cells with mitochondrial membrane label and increased mitochondrial membrane potential labeling. There was a decrease in the number of live cells and an increase in the number of apoptotic cells by caused hypoxanthine. Our findings show that intrastriatal hypoxanthine administration altered neuroenergetic parameters, and caused mitochondrial dysfunction and cell death by apoptosis, suggesting that these processes may be associated, at least in part, with neurological symptoms found in patients with Lesch-Nyhan Disease.


Asunto(s)
Envejecimiento/patología , Cuerpo Estriado/patología , Metabolismo Energético , Hipoxantina/farmacología , Animales , Muerte Celular/efectos de los fármacos , Creatina Quinasa/metabolismo , Complejo IV de Transporte de Electrones/metabolismo , Hipoxantina/administración & dosificación , Masculino , Mitocondrias/efectos de los fármacos , Mitocondrias/metabolismo , Piruvato Quinasa/metabolismo , Ratas Wistar , Succinato Deshidrogenasa/metabolismo
2.
Mol Neurobiol ; 54(4): 2790-2800, 2017 05.
Artículo en Inglés | MEDLINE | ID: mdl-27013467

RESUMEN

Hypoxanthine, the major oxypurine metabolite involved in purine's salvage pathway in the brain, is accumulated in Lesch-Nyhan disease, an inborn error of metabolism of purine. The purpose of this study was to investigate the effects of hypoxanthine intrastriatal administration on infant and young adult rats submitted to stereotactic surgery. We analyzed the effect of hypoxanthine on neuroinflammatory parameters, such as cytokine levels, immunocontent of NF-κB/p65 subunit, iNOS immunocontent, nitrite levels, as well as IBA1 and GFAP immunocontent in striatum of infant and young adult rats. We also evaluate some oxidative parameters, including reactive species production, superoxide dismutase, catalase, glutathione peroxidase activities, as well as DNA damage. Wistar rats of 21 and 60 days of life underwent stereotactic surgery and were divided into two groups: control (infusion of saline 0.9 %) and hypoxanthine (10 µM). Intrastriatal administration of hypoxanthine increased IL-6 levels in striatum of both ages of rats tested, while TNF-α increased only in 21-day-old rats. Hypoxanthine also increased nuclear immunocontent of NF-κB/p65 subunit in striatum of both ages of rats. Nitrite levels were decreased in striatum of 21-day-old rats; however, the immunocontent of iNOS was increased in striatum of hypoxanthine groups. Microglial and astrocyte activation was seen by the increase in IBA1 and GFAP immunocontent, respectively, in striatum of infant rats. All oxidative parameters were altered, suggesting a strong neurotoxic hypoxanthine role on oxidative stress. According to our results, hypoxanthine intrastriatal administration increases neuroinflammatory parameters perhaps through oxidative misbalance, suggesting that this process may be involved, at least in part, to neurological disorders found in patients with Lesch-Nyhan disease.


Asunto(s)
Cuerpo Estriado/metabolismo , Cuerpo Estriado/patología , Hipoxantina/administración & dosificación , Hipoxantina/farmacología , Inflamación/metabolismo , Inflamación/patología , Animales , Astrocitos/efectos de los fármacos , Astrocitos/metabolismo , Núcleo Celular/efectos de los fármacos , Núcleo Celular/metabolismo , Cuerpo Estriado/efectos de los fármacos , Citocinas/metabolismo , Citosol/metabolismo , Masculino , Microglía/efectos de los fármacos , Microglía/metabolismo , Óxido Nítrico Sintasa de Tipo II/metabolismo , Nitritos/metabolismo , Oxidación-Reducción/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , Ratas Wistar
3.
Zygote ; 24(2): 277-85, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-26083197

RESUMEN

The antioxidant properties of Amburana cearensis extract may be a useful substitute for standard cell culture medium. Thus, the aim of this study was to evaluate the effect of this extract, with or without supplementation, on in vitro survival and development of sheep isolated secondary follicles. After collection of the ovaries, secondary follicles were isolated and cultured for 18 days in α-MEM+ supplemented with bovine serum albumin, insulin, transferrin, selenium, glutamine, hypoxanthine and ascorbic acid (control medium) or into medium composed of different concentrations of A. cearensis extract without supplements (Amb 0.1; 0.2 or 0.4 mg/ml) or A. cearensis extract supplemented with the same substances described above for α-MEM+ supplementation. The A. cearensis supplemented medium was named Amb 0.1+; 0.2+ or 0.4+ mg/ml. There were more morphologically normal follicles in Amb 0.1 or Amb 0.4 mg/ml than in the control medium (α-MEM+) after 18 days of culture. Moreover, the percentage of antrum formation was significantly higher in Amb 0.1 or Amb 0.2 mg/ml than in α-MEM+ and Amb 0.1+ mg/ml, and similar to the other treatments. All A. cearensis extract media induced a progressive and significant increase in follicular diameter throughout the culture period. In conclusion, this study showed that 0.1 mg/ml of this extract, without supplementation, maintains follicular survival and promotes the development of ovine isolated secondary follicles in vitro. This extract can be an alternative culture medium for preantral follicle development.


Asunto(s)
Fabaceae/química , Folículo Ovárico/efectos de los fármacos , Extractos Vegetales/farmacología , Hojas de la Planta/química , Animales , Ácido Ascórbico/farmacología , Bovinos , Proliferación Celular/efectos de los fármacos , Forma de la Célula/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Femenino , Glutamina/farmacología , Hipoxantina/farmacología , Insulina/farmacología , Folículo Ovárico/citología , Folículo Ovárico/fisiología , Selenio/farmacología , Albúmina Sérica Bovina/farmacología , Ovinos , Transferrina/farmacología
4.
Cell Biochem Funct ; 32(4): 387-94, 2014 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-24578313

RESUMEN

In the present study, we investigated the in vitro effect of hypoxanthine on the activities of antioxidant enzymes such as catalase (CAT), superoxide dismutase (SOD) and glutathione peroxidase, as well as on thiobarbituric-acid-reactive substances (TBA-RS), in the renal cortex and medulla of rats. Results showed that hypoxanthine, at a concentration of 10.0 µM, enhanced the activities of CAT and SOD in the renal cortex of 15-, 30- and 60-day-old rats, enhanced SOD activity in the renal medulla of 60-day-old rats and enhanced TBA-RS levels in the renal medulla of 30-day-old rats, as compared with controls. Furthermore, we also verified the influence of allopurinol (an inhibitor of xanthine oxidase), as well as of the antioxidants, trolox and ascorbic acid on the effects elicited by hypoxanthine on the parameters tested. Allopurinol and/or administration of antioxidants prevented most alterations caused by hypoxanthine in the oxidative stress parameters evaluated. Data suggest that hypoxanthine alters antioxidant defences and induces lipid peroxidation in the kidney of rats; however, in the presence of allopurinol and antioxidants, some of these alterations in oxidative stress were prevented. Our findings lend support to a potential therapeutic strategy for this condition, which may include the use of appropriate antioxidants for ameliorating the damage caused by hypoxanthine.


Asunto(s)
Alopurinol/farmacología , Antioxidantes/farmacología , Ácido Ascórbico/farmacología , Hipoxantina/farmacología , Corteza Renal/efectos de los fármacos , Médula Renal/efectos de los fármacos , Oxidantes/farmacología , Estrés Oxidativo/efectos de los fármacos , Vitamina E/farmacología , Animales , Corteza Renal/metabolismo , Médula Renal/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Ratas Wistar
5.
J Neural Transm (Vienna) ; 120(9): 1359-67, 2013 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-23400363

RESUMEN

In the present study, we investigate the in vitro effect of hypoxanthine on acetylcholinesterase and butyrylcholinesterase activities in the hippocampus, striatum, cerebral cortex and serum of 15-, 30- and 60-day-old rats. Furthermore, we also evaluated the influence of antioxidants, namely α-tocopherol (trolox) and ascorbic acid, and allopurinol to investigate the possible participation of free radicals and uric acid in the effects elicited by hypoxanthine on these parameters. Acetylcholinesterase and butyrylcholinesterase activities were determined according to Ellman et al. (Biochem Pharmacol 7:88-95, 1961), with some modifications. Hypoxanthine (10.0 µM), when added to the incubation medium, enhanced acetylcholinesterase activity in the hippocampus and striatum of 15- and 30-day-old rats and reduced butyrylcholinesterase activity in the serum of 60-day-old rats. The administration of allopurinol and/or antioxidants partially prevented the alterations caused by hypoxanthine in acetylcholinesterase and butyrylcholinesterase activities in the cerebrum and serum of rats. Data indicate that hypoxanthine alters cholinesterase activities, probably through free radicals and uric acid production since the alterations were prevented by the administration of allopurinol and antioxidants. It is presumed that the cholinesterase system may be associated, at least in part, with the neuronal dysfunction observed in patients affected by Lesch-Nyhan disease. In addition, although extrapolation of findings from animal experiments to humans is difficult, it is conceivable that these vitamins and allopurinol might serve as an adjuvant therapy to avoid progression of brain damage in patients affected by this disease.


Asunto(s)
Alopurinol/farmacología , Antioxidantes/farmacología , Colinesterasas/metabolismo , Inhibidores Enzimáticos/farmacología , Hipoxantina/farmacología , Acetilcolinesterasa/metabolismo , Análisis de Varianza , Animales , Ácido Ascórbico/farmacología , Butirilcolinesterasa/metabolismo , Radicales Libres/metabolismo , Hipoxantina/líquido cefalorraquídeo , Síndrome de Lesch-Nyhan/metabolismo , Ratas , Ratas Wistar , Ácido Úrico/metabolismo , alfa-Tocoferol/farmacología
6.
Brain Res ; 1239: 198-206, 2008 Nov 06.
Artículo en Inglés | MEDLINE | ID: mdl-18775418

RESUMEN

The aim of this study was to investigate the effects of intrastriatal injection of hypoxanthine on ectonucleotidase (E-NTPDases and ecto-5'-nucleotidase) activities and expressions in the striatum of rats. The effect of pre-treatment with vitamins E and C on the effects elicited by this oxypurine on enzymatic activities and on thiobarbituric reactive substances (TBARS) was also investigated. The effect of pre-incubation with hypoxanthine on nucleotide hydrolysis in striatum homogenate was also determined. Adult Wistar rats were divided into (1) control and (2) hypoxanthine-injected groups. For ectonucleotidase activity determination, the animals were sacrificed at 30 min, 24 h and 7 days after drug infusion. For the evaluation of the expression of NTPDase 1-3 and also ecto-5'-nucleotidase, TBARS assay and the influence of the pre-treatment with vitamins on ectonucleotidase activities, the animals were sacrificed 24 h after hypoxanthine infusion. Results show that hypoxanthine infusion significantly inhibited ectonucleotidase activities and increased TBARS only 24 h after administration. Pre-treatment with vitamins was able to prevent these effects. Moreover, ecto-5'-nucleotidase expression was increased (80%) at 24 h after hypoxanthine infusion. We suggest that these hypoxanthine-induced biochemical modifications could, at least in part, participate in the pathophysiology of Lesch Nyhan disease.


Asunto(s)
Adenosina Trifosfatasas/metabolismo , Fármacos del Sistema Nervioso Central/farmacología , Cuerpo Estriado/efectos de los fármacos , Cuerpo Estriado/enzimología , Hipoxantina/farmacología , 5'-Nucleotidasa/metabolismo , Animales , Antígenos CD/metabolismo , Apirasa/metabolismo , Ácido Ascórbico/administración & dosificación , Ácido Ascórbico/farmacología , Fármacos del Sistema Nervioso Central/administración & dosificación , Cuerpo Estriado/metabolismo , Hidrólisis/efectos de los fármacos , Hipoxantina/administración & dosificación , Masculino , Nucleótidos/metabolismo , Pirofosfatasas/metabolismo , Ratas , Ratas Wistar , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismo , Factores de Tiempo , Vitamina E/administración & dosificación , Vitamina E/farmacología , Vitaminas/administración & dosificación , Vitaminas/farmacología
7.
Pharmacol Biochem Behav ; 90(4): 594-7, 2008 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-18547623

RESUMEN

The aim of this study was to investigate the effects of intrastriatal injection of hypoxanthine, the major compound accumulated in Lesch-Nyhan disease, on performance step-down inhibitory avoidance task in the rat. Male adult Wistar rats were divided in two groups: (1) saline-injected and (2) hypoxanthine-injected group. Treated-group received intrastriatal hypoxanthine solution 30 min before training session (memory acquisition) or immediately after training session (memory consolidation) or 30 before test session (memory retrieval) on step-down inhibitory avoidance task. Results show that hypoxanthine administration caused significant memory impairment in all periods tested. These results show that intrastriatal hypoxanthine administration provoked memory process impairment of step-down inhibitory avoidance task, an effect that might be related to the cognitive memory alterations in Lesch-Nyhan patients.


Asunto(s)
Reacción de Prevención/efectos de los fármacos , Hipoxantina/farmacología , Memoria/efectos de los fármacos , Animales , Ganglios Basales/fisiología , Hipoxantina/administración & dosificación , Masculino , Microinyecciones , Neostriado , Ratas , Ratas Wistar , Técnicas Estereotáxicas
8.
Drug Metabol Drug Interact ; 21(1): 19-29, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16086553

RESUMEN

Vimang is an aqueous extract of Mangifera indica used in Cuba to improve the quality of life in patients suffering from inflammatory diseases. In the present study we evaluated the effects of Vimang at preventing reactive oxygen species (ROS) formation and lipid peroxidation in intact isolated rat hepatocytes. Vimang at 20, 50 and 100 microg/ml inhibited hepatocyte ROS formation induced by glucose-glucose oxidase. Hepatocyte cytotoxicity and lipid peroxidation induced by cumene hydroperoxide was also inhibited by Vimang in a dose and time dependent manner at the same concentration. Vimang also inhibited superoxide radical formation by xanthine oxidase and hypoxanthine. The superoxide radical scavenging and antioxidant activity of the Vimang extract was likely related to its gallates, catechins and mangiferin content. To our knowledge, this is the first report of cytoprotective antioxidant effects of Vimang in cellular oxidative stress models.


Asunto(s)
Hepatocitos/efectos de los fármacos , Peroxidación de Lípido/fisiología , Extractos Vegetales/farmacología , Especies Reactivas de Oxígeno/metabolismo , Animales , Antioxidantes/farmacología , Derivados del Benceno/farmacología , Supervivencia Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Ácido Gálico/farmacología , Glucosa Oxidasa/farmacología , Hepatocitos/metabolismo , Hipoxantina/farmacología , Masculino , Mangifera , Oxidantes/farmacología , Estrés Oxidativo/efectos de los fármacos , Galato de Propilo/farmacología , Ratas , Ratas Sprague-Dawley , Superóxidos/metabolismo , Xantina Oxidasa/metabolismo
9.
Brain Res ; 1041(2): 198-204, 2005 Apr 18.
Artículo en Inglés | MEDLINE | ID: mdl-15829228

RESUMEN

The main objective of this study was to investigate the effects of preincubation of rat striatum homogenate in the presence of hypoxanthine, a metabolite accumulated in Lesch-Nyhan disease, on Na+,K+-ATPase activity and on some parameters of oxidative stress namely thiobarbituric acid-reactive substances (TBA-RS), total radical-trapping antioxidant parameter (TRAP) and membrane protein thiol content. Results showed that hypoxanthine significantly increased TBA-RS and reduced Na+,K+-ATPase activity, TRAP and membrane protein thiol content. In addition, we also evaluated the effect of glutathione, trolox, allopurinol and Nvarpi-nitro-L-arginine methyl ester (L-NAME) on the inhibitory effect of hypoxanthine on Na+,K+-ATPase activity in the same rat cerebral structure. All tested compounds per se did not alter Na+,K+-ATPase activity, but only glutathione and trolox prevented the effect of hypoxanthine on the enzyme activity. The effect of glutathione and trolox on hypoxanthine-induced increase of TBA-RS levels was also investigated. These antioxidants alone or combined with hypoxanthine reduced TBA-RS levels. Our present findings show that hypoxanthine induces oxidative stress in rat striatum and that the inhibition of Na+,K+-ATPase activity caused by this oxypurine was probably mediated by reactive oxygen species. It is presumed that these results might be associated with the neuronal dysfunction of patients affected by Lesch-Nyhan disease.


Asunto(s)
Cuerpo Estriado/efectos de los fármacos , Hipoxantina/farmacología , Neuronas/efectos de los fármacos , Estrés Oxidativo/efectos de los fármacos , ATPasa Intercambiadora de Sodio-Potasio/efectos de los fármacos , Animales , Antioxidantes/farmacología , Cuerpo Estriado/enzimología , Cuerpo Estriado/fisiopatología , Inhibidores Enzimáticos/farmacología , Radicales Libres/metabolismo , Síndrome de Lesch-Nyhan/metabolismo , Proteínas de la Membrana/química , Proteínas de la Membrana/efectos de los fármacos , Proteínas de la Membrana/metabolismo , Modelos Neurológicos , Neuronas/química , Neuronas/enzimología , Estrés Oxidativo/fisiología , Ratas , Ratas Wistar , ATPasa Intercambiadora de Sodio-Potasio/metabolismo , Fracciones Subcelulares , Compuestos de Sulfhidrilo/metabolismo , Membranas Sinápticas/efectos de los fármacos , Membranas Sinápticas/enzimología , Transmisión Sináptica/efectos de los fármacos , Transmisión Sináptica/fisiología , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismo
10.
Int J Dev Neurosci ; 22(1): 11-7, 2004 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-15013074

RESUMEN

In the present study, we investigated the in vitro effect of hypoxanthine, xanthine and uric acid, metabolites accumulating in tissue of patients with Lesch-Nyhan disease, on Na(+), K(+)-ATPase activity in striatum of neonate rats. Results showed that all compounds significantly inhibited Na(+), K(+)-ATPase activity. We also studied the kinetics of the inhibition of Na(+), K(+)-ATPase activity caused by hypoxanthine. The apparent K(m) and V(max) of Na(+), K(+)-ATPase activity for ATP as the substrate and hypoxanthine as the inhibitor were 0.97 mM and 0.69 nmol inorganic phosphate (Pi) released per min per mg of protein, respectively. K(i)-value was 1.9 microM, and the inhibition was of the non-competitive type. We also observed that the inhibitory effects of hypoxanthine, xanthine and uric acid probably occur through the same mechanism, suggesting a common binding site for these oxypurines on Na(+), K(+)-ATPase. Therefore, it is conceivable that inhibition of brain Na(+), K(+)-ATPase activity may be involved at least in part in the neuronal dysfunction characteristic of patients with Lesch-Nyhan disease.


Asunto(s)
Cuerpo Estriado/efectos de los fármacos , Síndrome de Lesch-Nyhan/metabolismo , ATPasa Intercambiadora de Sodio-Potasio/antagonistas & inhibidores , Membranas Sinápticas/efectos de los fármacos , Análisis de Varianza , Animales , Animales Recién Nacidos , Cuerpo Estriado/enzimología , Relación Dosis-Respuesta a Droga , Interacciones Farmacológicas , Humanos , Hipoxantina/farmacología , Técnicas In Vitro , Cinética , Modelos Lineales , Ratas , Ácido Úrico/farmacología , Xantina/farmacología
11.
Anim Reprod Sci ; 81(3-4): 273-86, 2004 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-14998653

RESUMEN

The development of culture systems to support the initiation of growth of primordial follicles is important to the study of the factors that control the earliest stages of folliculogenesis. We investigated the effectiveness of five culture media, two supplements and three culture periods on the survival and growth of goat primordial follicles after culturing ovarian cortex. The media were based on minimal essential minimum (MEM) and coconut water solution (CWS) added in the proportion of 0, 25, 50, 75 or 100%. The two supplements were none versus supplemented with insulin-transferrin-selenium, pyruvate, glutamine, hypoxanthine, and BSA. Pieces of goat ovarian cortex were cultured in the media for 1, 3 or 5 days and representative samples were evaluated at day 0 as non-cultured controls. The replicates were the two ovaries of five mixed breed goats. The number of primordial, intermediate, primary and secondary follicles at each period of culture and the number of degenerated follicles were evaluated. Mitotic activity of granulosa cells was studied by immunolocalization of proliferating cell nuclear antigen (PCNA). The number of follicles in each stage and degenerated follicles were statistically analyzed by ANOVA using a factorial design and the significance of differences assessed using Tukey test. Chi-square test was used to compare the percentage of follicles with PCNA positive granulosa cells. As the culture period progressed, the number of primordial follicles fell and there was a significant increase in the number of primary follicles. The fall in the number of primordial follicles was particularly marked after 1 day culture. No effect of media on the number of primordial and primary follicles was observed after culture, but MEM as well as supplements increased the number of intermediate follicles. Follicular degeneration was kept at the same level after culture in the media tested, except for pure CWS that increased the number of degenerated follicles. In contrast, addition of supplements to culture media reduced follicular degeneration. In non-cultured tissue, PCNA was expressed in granulosa cells of 31.6% of the growing follicles. This percentage had not significantly changed after 5 days culture in the various media, indicating the maintenance of proliferation activity of granulosa cells during culture. In conclusion, it is shown that goat primordial follicles may be successfully activated after in vitro culture in all media tested. However, when pure CWS is used the follicular degeneration is enhanced, but the addition of supplements to culture media decrease follicular degeneration.


Asunto(s)
Cocos , Medios de Cultivo , Cabras/fisiología , Folículo Ovárico/fisiología , Ovario/fisiología , Agua , Animales , División Celular/efectos de los fármacos , Técnicas de Cultivo , Femenino , Glutamina/farmacología , Células de la Granulosa/citología , Hipoxantina/farmacología , Insulina/farmacología , Folículo Ovárico/efectos de los fármacos , Ácido Pirúvico/farmacología , Selenio/farmacología , Albúmina Sérica Bovina/farmacología , Soluciones , Transferrina/farmacología
12.
Teratog Carcinog Mutagen ; 21(2): 109-19, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11223889

RESUMEN

The ability of the ventral prostate cytosolic fractions to biotransform ethanol to acetaldehyde and 1-hydroxyethyl (1HEt) radicals was tested. Acetaldehyde formation was determined by GC-FID analysis in the head space of incubation mixtures. 1HEt was determined by spin trapping with PBN followed by extraction, silylation of the adduct and GC-MS of the product. Prostate cytosol was able to biotransform ethanol to acetaldehyde in the presence of NADH, hypoxanthine, xanthine, caffeine, theobromine, theophylline, and 1,7-dimethylxanthine but not in the presence of N-methylnicotinamide. All these biotransformations were inhibited by allopurinol and were sensitive to heating for 5 min at 100 degrees C. The biotransformation of ethanol to acetaldehyde in the presence of purines as cosubstrates was accompanied by the formation of hydroxyl and 1HEt radicals as detected by GC-MS, and the process was inhibited by allopurinol. Results suggest that prostate cytosolic xanthine oxidase is able to bioactivate ethanol to acetaldehyde and free radicals. The potential of these processes to be involved in tumor-promoting effects of heavy alcohol drinking in conjunction with high meat and/or purines consumption is analyzed. Multifactorial epidemiological studies considering that possibility might be convenient. Teratogenesis Carcinog. Mutagen. 21:109-119, 2001.


Asunto(s)
Acetaldehído/metabolismo , Consumo de Bebidas Alcohólicas/efectos adversos , Carcinógenos , Etanol/metabolismo , Radicales Libres/metabolismo , Neoplasias/inducido químicamente , Próstata/enzimología , Xantina Oxidasa/metabolismo , Alopurinol/farmacología , Animales , Antimetabolitos/farmacología , Cafeína/farmacología , Cromatografía de Gases , Citosol/metabolismo , Dieta , Inhibidores Enzimáticos/farmacología , Cromatografía de Gases y Espectrometría de Masas , Hipoxantina/farmacología , Masculino , Carne , NAD/farmacología , Niacinamida/análogos & derivados , Niacinamida/farmacología , Inhibidores de Fosfodiesterasa/farmacología , Neoplasias de la Próstata/inducido químicamente , Neoplasias de la Próstata/etiología , Purinas/farmacología , Ratas , Ratas Sprague-Dawley , Detección de Spin , Temperatura , Teobromina/farmacología , Teofilina/farmacología , Factores de Tiempo , Vasodilatadores/farmacología , Xantina/farmacología
13.
Free Radic Biol Med ; 25(8): 875-80, 1998 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-9840731

RESUMEN

Pyridoxal isonicotinoyl hydrazone (PIH) has previously been studied for use in iron chelation therapy in iron-overload diseases. It is an efficient in vitro antioxidant due to its Fe(III) complexing activity (Schulman, H. M., et al. Redox Report 1:373-378; 1995). Pathologies associated with iron-overload include hepatic and other cancers. Since oxidative alterations of DNA can be linked to the development of cancer, we decided to study whether PIH protects DNA against in vitro oxidative stress. We report here that pUC-18 plasmid DNA is damaged by *OH radicals generated from Fe(II) plus H2O2 or from Fe(II) plus hypoxanthine/xanthine oxidase. The DNA damage was quantified by determining the diminution of supercoiled DNA forms after oxidative attack using agar gel electrophoresis. Micromolar amounts of PIH (20-30 microM) were able to half-protect DNA from iron (1-7.5 microM)-mediated *OH formation. The antioxidant capacity of PIH was significantly higher than that of some of its analogs and desferrioxamine. PIH and some of its analogues could also inhibit the oxidative degradation of 2-deoxyribose caused by Fenton reagents. Since we observed that PIH enhances the Fe(II) autoxidation rate, measured by the ferrozine technique, PIH may limit *OH formation and consequently DNA damage by decreasing the amount of Fe(II) available to catalyze Fenton reactions.


Asunto(s)
Antioxidantes , Daño del ADN/efectos de los fármacos , Radical Hidroxilo/farmacología , Quelantes del Hierro/farmacología , Isoniazida/análogos & derivados , Plásmidos/genética , Piridoxal/análogos & derivados , Compuestos Ferrosos/química , Radical Hidroxilo/metabolismo , Hipoxantina/farmacología , Isoniazida/farmacología , Oxidación-Reducción , Piridoxal/farmacología , Xantina Oxidasa/farmacología
14.
Placenta ; 18(4): 327-32, 1997 May.
Artículo en Inglés | MEDLINE | ID: mdl-9179926

RESUMEN

Uptake and metabolism of hypoxanthine by human placenta were studied using the single-circulation paired-tracer technique. In isolated cotyledons perfused through the fetal (basal) circulation, at mean pressures of 31.7 +/- 4.0 mmHg and mean flow rates maintained at 5.5 +/- 0.15 ml/min, the [3H]hypoxanthine uptake was 36 +/- 2.4 per cent (16.5 +/- 1.1 pmol/g wet weight). Hypoxanthine uptake was significantly inhibited by unlabelled (mM) hypoxanthine (0.5), adenine (0.5), guanine (0.5) and papaverine (15.0), but was unaffected by nitrobenzylthioinosine (0.01). Adenosine failed to inhibit hypoxanthine uptake. The kinetic analysis of hypoxanthine uptake showed it to be partially mediated by a saturable (apparent K(m) = 12.1 +/- 1.85 microns; Jmax = 7.1 +/- 0.52 nmol/min) and Na(+)-dependent mechanism. A greater fraction of hypoxanthine influx proceeded through a non-saturable process. Thin layer chromatographic analysis of venous perfusate after the intra-arterial injection of [3H]hypoxanthine showed a negligible degradation of nucleobase. These overall results show that hypoxanthine uptake at the fetal side of human placenta occurs by a saturable plus a non-saturable process. The carrier showed specificity for nucleobases and high affinity-low capacity for hypoxanthine. Since the fetal blood concentration of hypoxanthine is normally low, its uptake would be mediated by the high affinity transport system. Because the non-saturable mechanism can be operative at high concentrations of hypoxanthine, it may have primary importance to clear the nucleobase coming from the fetus during intrauterine hypoxia.


Asunto(s)
Hipoxantina/metabolismo , Placenta/metabolismo , Adenina/farmacología , Adenosina/farmacología , Transporte Biológico , Velocidad del Flujo Sanguíneo , Femenino , Feto/metabolismo , Guanina/farmacología , Humanos , Hipoxantina/farmacología , Papaverina/farmacología , Placenta/irrigación sanguínea , Embarazo , Sodio/farmacología , Tritio
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA